Sponsored Links
| FDA Orders Halt To Marketing Of Unapproved Single-ingredient Oral Colchicine |
 |
 |
 |
| Medical News - Gout | |||
|
The U.S. Food and Drug Administration took action against companies that manufacture, distribute, and/or market unapproved single-ingredient oral colchicine, a medication commonly used for the daily prevention of gout, to treat acute gout flare-ups, and for the treatment of Familial Mediterranean Fever (FMF)... Read more: Gout News From Medical News Today
|